James Hazel

ATMI Research Programme Manager @ Access to Medicine Foundation

[Suzanne Wolf @SuzanneWolfATMI]

Rond 17:30 live op @nieuwsenco op @NPORadio1 @VerhoefMarijn over de @AtMIndex en #opkomendeinfectieziekten. #access2meds @JayasreeKIyer @minbuza @LSchreinemacher @JamesWHazel @Zurhake @julietboogaard @MeritBoersma @CarlijneVos

[Access to Medicine Foundation @AtMIndex]

Today is International Childhood Cancer Day. Our 2021 Index IDed only 10 R&D projects that targeted childhood cancer - out of 1073 projects run by 20 of the world's biggest #pharma co.s. The 2022 Index will track whether this is improving #ICCD2022
➡️https://t.co/vAq23i9teI

[Access to Medicine Foundation @AtMIndex]

Thank you to all panelists and participants of our Amsterdam Session on #globalhealth security yesterday. We will publish a meeting report covering the critical take-aways in the coming weeks📈 https://t.co/Ze8K9e5wwW

[Access to Medicine Foundation @AtMIndex]

Today #WorldCancerDay focuses on the equity gap within cancer care - 10 mil die each year from cancer, 70% in lower-income countries. Our Index lays out missed chances for #pharma to use equitable pricing to #CloseTheCareGap👉https://t.co/DhDLF53Kty

[Access to Medicine Foundation @AtMIndex]

Experts from #pharma, govt and procurement agencies are joining us today to find practical solutions to prevent shortages & stockouts of meds and #vaccines. #COVID19 exposed cracks in global supply chains, putting #globalhealth security at risk. https://t.co/uZvDyoxfE7

[Access to Medicine Foundation @AtMIndex]

How will 20 of the world’s largest #pharma companies be assessed and ranked in the next Access to Medicine Index? Find out in our new Methodology Report, online now 👉https://t.co/NeIySPdrkV